Next Article in Journal
Viability and Desiccation Resistance of Bartonella henselae in Biological and Non-Biological Fluids: Evidence for Pathogen Environmental Stability
Next Article in Special Issue
Emerging and Reemerging Parasitic Diseases in Taiwan: A Retrospective Study of Clinical Case Reports in 2001~2018
Previous Article in Journal
In Vitro Activity of Isavuconazole and Amphotericin B in Association against Mucorales
Previous Article in Special Issue
Differential Analysis of Key Proteins Related to Fibrosis and Inflammation in Soluble Egg Antigen of Schistosoma mansoni at Different Infection Times
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Cystatins from the Human Liver Fluke Opisthorchis viverrini: Molecular Characterization and Functional Analysis

1
Graduate Program in Biomedical Sciences, Faculty of Allied Health Sciences, Thammasat University, Khlong Luang, Pathum Thani 12120, Thailand
2
Thailand Institute of Scientific and Technological Research, Khlong Luang, Pathum Thani 12120, Thailand
3
Chulabhorn International College of Medicine, Thammasat University, Khlong Luang, Pathum Thani 12120, Thailand
4
Department of Preclinical Science, Faculty of Medicine, Thammasat University, Khlong Luang, Pathum Thani 12120, Thailand
*
Author to whom correspondence should be addressed.
Pathogens 2023, 12(7), 949; https://doi.org/10.3390/pathogens12070949
Submission received: 30 June 2023 / Revised: 16 July 2023 / Accepted: 17 July 2023 / Published: 18 July 2023
(This article belongs to the Special Issue Parasite Infection and Tropical Infectious Diseases)

Abstract

:
A high incidence of cholangiocarcinoma (bile duct cancer) has been observed in Thailand. This usually rare cancer has been associated with infection with the human liver fluke, Opisthorchis viverrini. Secretions of the parasite that interact with the host are thought to be a major component of its pathogenicity and proteolysis is a key biological activity of the secreted molecules. In this study, we present a molecular analysis of cysteine proteinase inhibitors (cystatins) of Opisthorchis viverrini. Six cDNA coding sequences of Opisthorchis viverrini cystatins, OvCys1–6, were cloned from the adult stage of the parasite using RT-PCR. Based on their sequences, OvCys1 and OvCys2 are classified as type 1 cystatins, while OvCys3–6 are classified as type 2 cystatins, with each containing a signal peptide and only one C-terminal disulfide bond. Their C-terminal region sequences are diverse compared with other cystatin members. Cystatins OvCys1, 3 and 4 were found in crude worm extracts and excretory-secretory (ES) products from the adult parasite using Western blot detection, while the other isoforms were not. Thus, OvCys1, 3 and 4 were selected for inhibition analysis and immune reactivity with Opisthorchis viverrini-infected hamster sera. OvCys1, 3, and 4 inhibited mammalian cathepsin L more effectively than cathepsin B. The pH range for their full activity was very wide (pH 3–9) and they were heat stable for at least 3 h. Unlike Fasciola gigantica cystatins, they showed no immune reactivity with infected hamster sera based on indirect ELISA. Our findings suggest that Opisthorchis viverrini cystatins are not major antigenic components in the ES product of this parasite and that other effects of Opisthorchis viverrini cystatins should be investigated.

1. Introduction

The human liver fluke, Opisthorchis viverrini, is classified as a group I carcinogen that causes cholangiocarcinoma (CCA). This cancer type has a high incidence in Thailand and other countries in Southeast Asia [1,2,3]. One proposed mechanism contributing to CCA through chronic infection is the damage caused by components of the excretory-secretory (ES) products of the parasites. The released proteins can cause the induction of cell proliferation and inhibition of DNA repair/apoptosis [3,4]. Proteinases and their inhibitors are major components in the ES products of many parasites and are involved with many biological functions in parasites, including nutrition, immunomodulation and host-tissue digestion [5,6,7]. Consequently, it is necessary to develop strategies that interrupt parasite infection. Proteinase inhibitors are of interest as they not only regulate the proteinases of the parasite but also those of the host. A few cystatins have been molecularly characterized in the trematodes Schistosoma sp., Fasciola sp., and Clonorchis sinensis, for example, two Fasciola gigantica cystatins, both classified as type 1 cystatin, were found to be involved with regulating intracellular cysteine proteinase activity and protecting against extracellular proteolytic processes [8,9,10,11,12,13,14]. From our previous study of type 3 multi-domain cystatin in Fasciola gigantica, we found that processed cystatin domains inhibited both parasite and mammalian cysteine proteinases. We speculated that the processed domains were functional during spermiogenesis and fertilization. The major proteinases released by adult Opisthorchis viverrini are cysteine proteinases: cathepsins F and B. Both Opisthorchis viverrini cathepsins can digest human hemoglobin and extracellular matrix proteins, contributing to the development of CCA [15,16]. However, there are no laboratory data showing the functions and properties of Opisthorchis viverrini cysteine proteinase inhibitors. Through screening of transcriptome and genome databases of Opisthorchis viverrini [17,18], we found six transcripts/genes encoding cystatin type 1 and type 2 in adult Opisthorchis viverrini. Here, we have molecularly characterized these six Opisthorchis viverrini cystatins (OvCys1–6). Their sequence similarity is relatively low, except between OvCys1 and OvCys2. The native cystatins were found in the ES product of the adult stage, even though some of them contain no signal peptide. The inhibition properties were analyzed with mammalian cathepsins B and L, as was the stability at different pH values and high temperatures. This study contributes to our understanding of their biological functions. Other properties of Opisthorchis viverrini cystatins, such as anti-inflammatory effects, remain to be analyzed.

2. Materials and Methods

2.1. Parasites

Metacercariae of O. viverrini were collected from naturally infected fish. Female Syrian golden hamsters were infected with 100 metacercariae via gastric intubation. Adult O. viverrini were collected from the livers and bile ducts of 12-week-infected hamsters. The worms were washed twice in 0.85% normal saline solution and kept in liquid nitrogen until used in further experiments. The animal use protocol for all animal experiments in this study was approved by the Thammasat University Animals Ethics Committee (12 February 2020, Protocol No. 033/2561).

2.2. Molecular Cloning and Sequence Analysis

Total RNA was extracted from adult worms in TRIzol reagent (Invitrogen, Carlsbad, CA, USA) and used as a template for RT-PCR as described in our previous study [10,19]. Gene-specific primer pairs were designed from transcriptome/genome databases of O. viverrini [17,18], as detailed in Table 1. The PCR products were ligated into pGEM-T Easy (Promega, Madison, WI, USA) and the inserted sequences were determined by 1st BASE Sequencing Asia. EMBOSS (EMBOSS programs < EMBL-EBII) and SignalP 6.0 [20] were used to edit and analyze the sequences. MUSCLE version 5.2 https://www.drive5.com/muscle/ (accessed 29 May 2023) was used for multiple sequence alignment of O. viverrini cystatins (OvCys1–6) and human cystatin C (UniProtKB: P01034). The AlphaFold Protein Structure Database at “https://alphafold.ebi.ac.uk (accessed 14 July 2023)” was used to obtain models of the O. viverrini cystatins [21].

2.3. Expression of Recombinant Opisthorchis viverrini Cystatins and Production of rOvCys1–6 Antisera

The coding DNA sequences of six Opisthorchis viverrini cystatins (OvCys1–6) were subcloned into the expression plasmid pQE30 (QIAGEN, Hilden, Germany) using restriction sites introduced by the listed primers (Table 1). The recombinant plasmids were sequenced by 1st BASE Sequencing Asia. Escherichia coli M15 was used as an expression host, with induction by IPTG at 1 mM final concentration. Due to the insolubility of the expressed recombinant proteins, all Opisthorchis viverrini cystatins were purified under denaturing conditions using Ni-NTA affinity-chromatography, following the protocols in the QIAExpressionist manual (QIAGEN, Germany). Antisera against recombinant Opisthorchis viverrini cystatins were produced in ICR mice (two female mice per antigen) via the intraperitoneal cavity. Ten micrograms of each antigen were used to immunize mice three times in 3-week intervals. Pre-immune and immune sera were stored at −20 °C for further immunological experiments.

2.4. Parasite Antigen Preparation

Adult parasite-soluble crude worm extract (CWE) and excretory-secretory (ES) products were prepared as described [22]. Briefly, 200 adult O. viverrini worms were homogenized in lysis buffer using an UltraTurrax T25 tissue homogenizer (IKA, Staufen, Germany). The supernatant was collected as soluble CWE and used for further experiments. The ES product was prepared from fresh adult O. viverrini. A total of 500 worms were washed with normal saline solution and then incubated in 0.01 M PBS, pH 7.2, in 5% CO2 at 37 °C. The buffer was collected and centrifuged to eliminate insoluble material. The supernatant was concentrated using a centrifugal concentrator (3 kDa cut-off, GE Healthcare, Buckinghamshire, UK). Protein concentrations were measured using Bradford assay (Bio-Rad, Hercules, CA, USA).

2.5. SDS-PAGE and Western Blot Analysis

Twenty micrograms of each O. viverrini CWE and ES product and 100 ng of recombinant O. viverrini cystatins were size-separated using 16% SDS-PAGE and transferred to nitrocellulose membranes (Bio-Rad, Hercules, CA, USA) via semi-dry transfer using a Fastblot B33 instrument (Whatman, Biometra, Germany). Antisera specific to each recombinant cystatin and pre-immunized sera at a dilution of 1:1000 were used to probe the bound proteins. Alkaline phosphatase goat anti-mouse IgG (Sigma, Saint Louis, MO, USA) was used as a secondary antibody at a dilution of 1:30,000. The immune complex was enzymatically detected using BCIP/NBT phosphatase substrate (Amresco, Solon, OH, USA).
The cross-reactivity of each O. viverrini cystatin antiserum was investigated. To this effect, 100 ng of each recombinant cystatin was size-separated using SDS-PAGE, transferred to nitrocellulose membranes, and probed with antisera at the same dilution and via the same process described above.

2.6. Reactivity of Sera from Opisthorchis Viverrini-Infected Hamsters with Recombinant OvCys1, 3 and 4

OvCys1, 3 and 4 were tested with O. viverrini-infected hamster sera sampled 12 weeks post-infection (12 wpi, n = 10) and compared with normal hamster sera (0 weeks post-infection, 0 wpi, n = 10) using indirect ELISA. Recombinant H1_OvROPN1L was used as a positive control [23]. Briefly, microtiter plates were coated with 100 ng of each antigen in carbonate buffer. Skim milk at a concentration of 1% (w/v) was used to block non-specific binding. Individual hamster sera were diluted at 1:100 in TBS, pH 7.5, and 0.1% (v/v) Tween-20. Goat anti-(Syrian) hamster IgG AP-conjugated antibody (Abcam, Cambridge, MA, USA) was used as the secondary antibody at a dilution of 1:1000. p-Nitrophenyl phosphate (pNPP) substrate (Sigma Aldrich, St. Louis, MO, USA) was added and absorbance values were measured at 405 nm.

2.7. Protein Refolding, Inhibitory Activities of Recombinant OvCys1, 3 and 4 against Mammalian (Bovine) Cathepsin B and L, and Their pH and Temperature Stability

The recombinant OvCys1, 3 and 4 expressed in the bacterial host system were selected and their inhibitory activities tested against bovine cathepsin B and L. Due to the insoluble form of these expressed recombinants, they were refolded by step-wise dialysis in urea buffer as described [10] in order to obtain their soluble functional forms. The inhibition coefficients (IC50), pH and temperature stability of the refolded cystatins were determined as previously described [11,12]. The residual inhibitory activity of the cystatins (1 μM) was measured after incubating in buffer at different pH values (pH 3–9) for 30 min and at high temperature (99 °C) for 0–180 min. Soluble recombinant FgStefin2 was used as a positive control [12]. Each experiment was conducted in triplicate. The raw data were normalized between 0 and 100% activity and fitted nonlinearly based on a dose–response simulation (variable slope) to obtain the IC50 values using GraphPad Prism 9.5, GraphPad Software (LLC, Portland, OR, USA).

3. Results

3.1. Molecular Cloning and Sequence Analysis

Six cDNA sequences encoding cysteine proteinase inhibitors (cystatins) were isolated from adult O. viverrini via RT-PCR using specific primers (see Section 2.2). The nucleotide sequences were submitted to GenBank database under accession no. OR047397–402 (Table 2). The cDNA size, molecular weight and core motif of each cystatin are shown in Table 2. Cystatins are classified into three types: type 1 cystatins (single domain without a signal peptide and disulfide bonds), type 2 cystatins (single domain with a signal peptide and disulfide bonds) and type 3 (multidomain cystatins) [24]. Based on their sequences, OvCys1 and 2 were classified as type 1 cystatins and the other four cystatins, OvCys3–6, were classified as type 2 cystatins (Figure 1). The C-termini of O. viverrini cystatins show low conservation compared with human cystatin C. Following AlphaFold models, OvCys3–5 might have two disulfide bonds (Figure 1). These are in different positions compared with those of human cystatin C. OvCys6 lacks one of the four cysteines and thus has only a single disulfide bond. The amino acid sequences of OvCys1 and 2 share 84% similarity, while OvCys3–6 are less similar (30–65%) (Table 3). This high sequence conservation may be the cause of the cross-reactivity of OvCys1 and 2 antisera, as described in Section 3.3. Additionally, four of the five active site residues in human cystatin C are conserved. The core motif follows the consensus pattern QhV.G. (h hydrophobic, any residue) in all O. viverrini cystatins.

3.2. Expression and Purification of Recombinant O. viverrini Cystatins and Antisera Production

O. viverrini cystatins (OvCys1–6) were successfully expressed as insoluble proteins in E. coli M15. They were purified under denaturing conditions and used in denatured form for antibody production. Antisera against the six recombinant O. viverrini cystatins were raised in two mice per antigen. The antisera were used to detect native cystatins in the parasite soluble extract and ES product. Insoluble recombinant OvCys1, 3 and 4 were solubilized via step-wise dialysis and their soluble forms were used for inhibition assays of mammalian cathepsin B and L (Section 3.5).

3.3. SDS-PAGE and Western Blot Analysis

Soluble crude worm extract (CWE) and ES products were prepared from adult O. viverrini. The quality and quantity of parasite extracts were analyzed as mentioned in Section 2.3 and Section 2.5. Twenty micrograms of each O. viverrini CWE and ES product were size-separated on 16% SDS-PAGE and used in western blot detection (Figure 2a). Western blot detection showed that only mouse anti-rOvCys1, 3 and 4 antisera reacted with their immunizing antigens (rOvCys1, 3 and 4) in CWE and ES product, with monomer, dimer and trimer forms (Figure 2b). Anti-rOvCys2, 5 and 6 antisera reacted with the recombinant proteins but not with the parasite extracts. The test for cross-reactivity between antisera against each isoform revealed that anti-OvCys1 cross-reacted with rOvCys2, whereas anti-OvCys2 did not react with rOvCys1 (Figure 2b). This is likely due to the high sequence conservation between OvCys1 and 2 (Table 3). This cross-reactivity indicates that native OvCys2 may also be detected by anti-OvCys1 antisera.

3.4. Reactivity of O. viverrini-Infected Hamster Antisera with Recombinant OvCys1, 3 and 4

Individual sera from O. viverrini-infected (12 wpi) and uninfected (0 wpi) hamsters (n = 10, each) were used to probe rOvCys1, 3 and 4 and to analyze binding using indirect ELISA (Figure 3). The recombinant H1 peptide of OvROPN1L was used as a positive control [23]. The recorded absorbance values of the sera of uninfected and infected hamsters were not statistically different.

3.5. Inhibition of Mammalian (Bovine) Cathepsin B and L by Recombinant OvCys1, 3 and 4, and pH and Temperature Stability

Purified soluble rOvCys1, 3 and 4 were tested for inhibitory activity against bovine cathepsin B and L. FgStefin2 was used as a positive control [12]. OvCys1, 3 and 4 were selected to test inhibition because their native forms were found in soluble CWE and ES products (see Section 3.3). OvCys1, 3 and 4 showed similar inhibition of cathepsin B but were less efficient than FgStefin2 (Figure 4). The IC50 values showed highest inhibition activity for OvCys1, followed by OvCys3 and OvCys4, respectively (Table 4). The inhibition of cathepsin L was similar for OvCys1 and OvCys3 and only slightly lower than for FgStefin2. OvCys4 had slightly lower inhibitory activity, as observed for pH and temperature stability of two F. gigantica cystatins, FgStefin1 and 2 [11,12]. OvCys1, 3 and 4 also showed stability over a wide range of temperatures and pH values (Figure 5).

4. Discussion

In the present research six potential cystatins of the human liver fluke Opisthorchis viverrini were analyzed to determine their molecular sequence, protein distribution, antigenicity, and inhibitory function. These inhibitors of cysteine proteinases are commonly found in eukaryotes [24] but are also present in a smaller number of bacteria and viruses (InterPro: IPR000010). Flukes are thought to require cystatins to control the activity of endogenous cysteine proteinases and proteinases released by the host. In the case of O. viverrini, the parasite has been found to release cathepsin B, L and F—cysteine proteinases that are required for the digestion of host proteins—into the host environment [15,25,26]. The six investigated cystatins are single-domain cystatins and fall into two groups: type 1 cystatin without a signal peptide and disulfide bonds represented by OvCys1 and OvCys2 and type 2 cystatins that possess both signal peptide and disulfide bonds and are represented by OvCys3–6. The type 1 OvCys1 and OvCys2 are highly conserved, at 72% identity/84% similarity, whereas the type 2 O. viverrini cystatins show lower sequence conservation. Low sequence conservation is common among cystatins with only a few residues, mainly those associated with activity, being conserved.
While the six cystatin-specific antisera were all reactive with their cognate recombinant proteins, only antisera against rOvCys1, rOvCys3 and rOvCys4 detected the native proteins in CWE and ES products. Possibly, the other three cystatins were only present in small amounts in CWE and ES products and immunogenic detection was not sensitive enough to detect them. Refolded, soluble rOvCys1, rOvCys3 and rOvCys4 showed cystatin-typical high stability at high temperatures and across a broad pH range. They inhibited cathepsin L better than cathepsin B, which is normally explained by the excluding loop in cathepsin B that interferes with binding. High inhibition of cathepsin B was found for a Fasciola gigantica cystatin expressed in the parasite’s prostate gland and was later also demonstrated for the homologous cystatin in F. hepatica [12,27]. The recombinant OvCys3–6 used in this study contained the signal peptide; in the case of rOvCys3 and rOvCys4, this did not seem to affect their function.
In contrast to observations made for cystatins from the liver fluke F. gigantica [11,12], there was no immune response against these proteins in O. viverrini-infected hamsters. Of course, antigens released by F. gigantica in the juvenile intrahepatic stage stimulate a stronger immune response than antigens released by O. viverrini, a much smaller parasite that does not feed on blood, elicit in the bile ducts. However, other O. viverrini proteins do stimulate an immune response [28,29]. One explanation might be the low molecular weight of cystatin (11–13 kDa) and its complexing with cysteine proteinases that limit the number and accessibility of epitopes and, consequently, lead to low antigenicity. Based on the results, these cystatins are not applicable for the diagnosis of infection. Whether they are suitable drug targets remains to be determined; however, this is doubtful as each of them can bind to many different cysteine proteinases and thus knocking out one cystatin might have little impact.
In recent years, the roles of cystatins in various diseases, for example in cancer where they can interfere with invasion and metastasis, have been uncovered (reviewed in [30,31,32]) and have renewed interest in these inhibitors as research targets. Immunomodulatory activities of cystatins have been reported not only in Mammalia but also in Nematoda, Platyhelminthes [27,33] and Arthropoda [34]. Within the trematodes, cystatins have for example been identified in the digestive tract, prostate gland and tegument and are thought to be important for the regulation of endo- and exogenous cysteine proteinases [11,12].

5. Conclusions

Six single-domain cystatins of Opisthorchis viverrini were investigated. Three of them were found to be released in the excretion-secretion product of the parasite but did not stimulate a detectable immune response within the first 12 weeks of infection in hamsters. Activity assays confirmed their inhibitory properties as well as heat and pH stability. Further studies of these proteins should focus on their potential immunomodulatory activities.

Author Contributions

Conceptualization, A.G.-K. and R.G.; methodology, A.G.-K., R.G., S.S. and N.K.; software, A.G.-K., D.K. and R.G.; validation, A.G.-K., S.S. and R.G.; formal analysis, A.G.-K., S.S. and R.G.; investigation, A.G.-K. and S.S.; resources, A.G.-K., W.P., N.K. and P.M.; data curation, A.G.-K. and R.G.; writing—original draft preparation, A.G.-K., R.G. and D.K.; writing—review and editing, A.G.-K., R.G., D.K. and P.M.; visualization, A.G.-K. and R.G.; supervision, R.G.; project administration, A.G.-K., W.P., S.S. and R.G.; funding acquisition, A.G.-K., R.G. and W.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by a Research Fund from the Faculty of Allied Health Sciences, Thammasat University (contract no. ทปค 2/2562), Thammasat University Research Unit in Parasitic Diseases and the Thailand Science Research and Innovation Fundamental Fund (contract no. TUFF11/2564). The APC was funded by the Thammasat University Research Unit of Parasitic Diseases and the Thailand Science Research and Innovation Fundamental Fund.

Institutional Review Board Statement

The animal study protocol was approved by the Institutional Care and Use Committee of Thammasat University (protocol approval no. 033/2561 from 12 February 2020).

Informed Consent Statement

Not applicable.

Data Availability Statement

Nucleic acid sequences were submitted to GenBank database, as mentioned in the main text. Other data supporting the findings of this study are available from the corresponding author upon request.

Acknowledgments

We would like to thank Wanlapa Chaibangyang (Faculty of Allied Health Sciences, Thammasat University) and Smarn Tesana (Faculty of Medicine, Khon Kaen University) for their help with collecting O. viverrini metacercariae.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Vatanasapt, V.; Tangvoraphonkchai, V.; Titapant, V.; Pipitgool, V.; Viriyapap, D.; Sriamporn, S. A high incidence of liver cancer in Khon Kaen Province, Thailand. Southeast Asian J. Trop. Med. Public. Health 1990, 21, 489–494. [Google Scholar]
  2. Green, A.; Uttaravichien, T.; Bhudhisawasdi, V.; Chartbanchachai, W.; Elkins, D.B.; Marieng, E.O.; Pairqjkul, C.; Dhiensiri, T.; Kanteekaew, N.; Haswell-Elkins, M.R. Cholangiocarcinoma in north east Thailand. A hospital-based study. Trop. Geogr. Med. 1991, 43, 193–198. [Google Scholar]
  3. Brindley, P.J.; da Costa, J.M.; Sripa, B. Why does infection with some helminths cause cancer? Trends. Cancer 2015, 1, 174–182. [Google Scholar] [CrossRef] [PubMed]
  4. Sripa, B.; Brindley, P.J.; Mulvenna, J.; Laha, T.; Smout, M.J.; Mairiang, E.; Bethony, J.M.; Loukas, A. The tumorigenic liver fluke Opisthorchis viverrine—Multiple pathways to cancer. Trends Parasitol. 2012, 28, 395–407. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. McKerrow, J.H.; Caffrey, C.; Kelly, B.; Loke, P.; Sajid, M. Proteases in parasitic diseases. Annu. Rev. Pathol. 2006, 1, 497–536. [Google Scholar] [CrossRef] [PubMed]
  6. Knox, D.P. Proteinase inhibitors and helminth parasite infection. Parasite Immunol. 2007, 29, 57–71. [Google Scholar] [CrossRef]
  7. Williamson, A.L.; Brindley, P.J.; Knox, D.P.; Hotez, P.J.; Loukas, A. Digestive proteases of blood-feeding nematodes. Trends Parasitol. 2003, 19, 417–423. [Google Scholar] [CrossRef]
  8. He, B.; Cai, G.; Ni, Y.; Li, Y.; Zong, H.; He, L. Characterization and expression of a novel cystatin gene from Schistosoma japonicum. Mol. Cell Probes 2011, 25, 186–193. [Google Scholar] [CrossRef] [PubMed]
  9. Morales, F.C.; Furtado, D.R.; Rumjanek, F.D. The N-terminus moiety of the cystatin SmCys from Schistosoma mansoni regulates its inhibitory activity in vitro and in vivo. Mol. Biochem. Parasitol. 2004, 134, 65–73. [Google Scholar] [CrossRef]
  10. Geadkaew, A.; Kosa, N.; Siricoon, S.; Grams, S.V.; Grams, R. A 170kDa multi-domain cystatin of Fasciola gigantica is active in the male reproductive system. Mol. Biochem. Parasitol. 2014, 196, 100–107. [Google Scholar] [CrossRef]
  11. Tarasuk, M.; Vichasri Grams, S.; Viyanant, V.; Grams, R. Type I cystatin (stefin) is a major component of Fasciola gigantica excretion/secretion product. Mol. Biochem. Parasitol. 2009, 167, 60–71. [Google Scholar] [CrossRef]
  12. Siricoon, S.; Grams, S.V.; Grams, R. Efficient inhibition of cathepsin B by a secreted type 1 cystatin of Fasciola gigantica. Mol. Biochem. Parasitol. 2012, 186, 126–133. [Google Scholar] [CrossRef]
  13. Kang, J.M.; Lee, K.H.; Sohn, W.M.; Na, B.K. Identification and functional characterization of CsStefin-1, a cysteine protease inhibitor of Clonorchis sinensis. Mol. Biochem. Parasitol. 2011, 177, 126–134. [Google Scholar] [CrossRef]
  14. Chantree, P.; Tarasuk, M.; Prathaphan, P.; Ruangtong, J.; Jamklang, M.; Chumkiew, S.; Martviset, P. Type I Cystatin Derived from Fasciola gigantica Suppresses Macrophage-Mediated Inflammatory Responses. Pathogens 2023, 12, 395. [Google Scholar] [CrossRef]
  15. Sripa, J.; Laha, T.; To, J.; Brindley, P.J.; Sripa, B.; Kaewkes, S.; Dalton, J.P.; Robinson, M.W. Secreted cysteine proteases of the carcinogenic liver fluke, Opisthorchis viverrini: Regulation of cathepsin F activation by autocatalysis and trans-processing by cathepsin B. Cell. Microbiol. 2010, 12, 781–795. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Mulvenna, J.; Sripa, B.; Brindley, P.J.; Gorman, J.; Jones, M.K.; Colgrave, M.L.; Jones, A.; Nawaratna, S.; Laha, T.; Suttiprapa, S.; et al. The secreted and surface proteomes of the adult stage of the carcinogenic human liver fluke Opisthorchis viverrini. Proteomics 2010, 10, 1063–1078. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Young, N.D.; Campbell, B.E.; Hall, R.S.; Jex, A.R.; Cantacessi, C.; Laha, T.; Sohn, W.-M.; Sripa, B.; Loukas, A.; Brindley, P.J.; et al. Unlocking the Transcriptomes of Two Carcinogenic Parasites, Clonorchis sinensis and Opisthorchis viverrini. PLoS Neglected Trop. Dis. 2010, 4, e719. [Google Scholar] [CrossRef]
  18. Young, N.D.; Nagarajan, N.; Lin, S.J.; Korhonen, P.K.; Jex, A.R.; Hall, R.S.; Safavi-Hemami, H.; Kaewkong, W.; Bertrand, D.; Gao, S.; et al. The Opisthorchis viverrini genome provides insights into life in the bile duct. Nat. Commun. 2014, 5, 4378. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Martviset, P.; Chantree, P.; Chaimon, S.; Torungkitmangmi, N.; Prathaphan, P.; Ruangtong, J.; Sornchuer, P.; Thongsepee, N.; Sangpairoj, K.; Adisakwattana, P. Molecular Cloning and Characterization of a Fasciola gigantica Nuclear Receptor Subfamily 1 (FgNR1). Pathogens 2022, 11, 1458. [Google Scholar] [CrossRef] [PubMed]
  20. Teufel, F.; Almagro Armenteros, J.J.; Johansen, A.R.; Gíslason, M.H.; Pihl, S.I.; Tsirigos, K.D.; Winther, O.; Brunak, S.; von Heijne, G.; Nielsen, H. SignalP 6.0 predicts all five types of signal peptides using protein language models. Nat. Biotechnol. 2022, 40, 1023–1025. [Google Scholar] [CrossRef] [PubMed]
  21. Varadi, M.; Anyango, S.; Deshpande, M.; Nair, S.; Natassia, C.; Yordanova, G.; Yuan, D.; Stroe, O.; Wood, G.; Laydon, A.; et al. AlphaFold Protein Structure Database: Massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 2022, 50, D439–D444. [Google Scholar] [CrossRef]
  22. Emmanoch, P.; Kosa, N.; Vichasri-Grams, S.; Tesana, S.; Grams, R.; Geadkaew-Krenc, A. Comparative Characterization of Four Calcium-Binding EF Hand Proteins from Opisthorchis viverrini. Korean J. Parasitol. 2018, 56, 81–86. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Geadkaew-Krenc, A.; Grams, R.; Phadungsil, W.; Chaibangyang, W.; Kosa, N.; Adisakwattana, P.; Dekumyoy, P. Evaluation of Rhophilin Associated Tail Protein (ROPN1L) in the Human Liver Fluke Opisthorchis viverrini for Diagnostic Approach. Korean J. Parasitol. 2020, 58, 475–479. [Google Scholar] [CrossRef] [PubMed]
  24. Turk, V.; Stoka, V.; Turk, D. Cystatins: Biochemical and structural properties, and medical relevance. Front. Biosci. 2008, 13, 5406–5420. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Kaewpitoon, N.; Laha, T.; Kaewkes, S.; Yongvanit, P.; Brindley, P.J.; Loukas, A.; Sripa, B. Characterization of cysteine proteases from the carcinogenic liver fluke, Opisthorchis viverrini. Parasitol. Res. 2008, 102, 757–764. [Google Scholar] [CrossRef]
  26. Pinlaor, P.; Kaewpitoon, N.; Laha, T.; Sripa, B.; Kaewkes, S.; Morales, M.E.; Mann, V.H.; Parriott, S.K.; Suttiprapa, S.; Robinson, M.W.; et al. Cathepsin F cysteine protease of the human liver fluke, Opisthorchis viverrini. PLoS Neglected Trop. Dis. 2009, 3, e398. [Google Scholar] [CrossRef]
  27. Zhang, K.; Liu, Y.; Zhang, G.; Wang, X.; Li, Z.; Shang, Y.; Ning, C.; Ji, C.; Cai, X.; Xia, X.; et al. Molecular Characteristics and Potent Immunomodulatory Activity of Fasciola hepatica Cystatin. Korean J. Parasitol. 2022, 60, 117–126. [Google Scholar] [CrossRef]
  28. Ruangsittichai, J.; Viyanant, V.; Vichasri-Grams, S.; Sobhon, P.; Tesana, S.; Upatham, E.S.; Hofmann, A.; Korge, G.; Grams, R. Opisthorchis viverrini: Identification of a glycine-tyrosine rich eggshell protein and its potential as a diagnostic tool for human opisthorchiasis. Int. J. Parasitol. 2006, 36, 1329–1339. [Google Scholar] [CrossRef]
  29. Rattanachan, S.; Grams, R.; Tesana, S.; Smooker, P.M.; Grams, S.V. Opisthorchis viverrini: Analysis of the sperm-specific rhophilin associated tail protein 1-like. Acta Trop. 2014, 140, 34–40. [Google Scholar] [CrossRef]
  30. Lalmanach, G.; Saidi, A.; Marchand-Adam, S.; Lecaille, F.; Kasabova, M. Cysteine cathepsins and cystatins: From ancillary tasks to prominent status in lung diseases. Biol. Chem. 2015, 396, 111–130. [Google Scholar] [CrossRef]
  31. Shamsi, A.; Bano, B. Journey of cystatins from being mere thiol protease inhibitors to at heart of many pathological conditions. Int. J. Biol. Macromol. 2017, 102, 674–693. [Google Scholar] [CrossRef] [PubMed]
  32. Breznik, B.; Mitrović, A.; Lah, T.T.; Kos, J. Cystatins in cancer progression: More than just cathepsin inhibitors. Biochimie 2019, 166, 233–250. [Google Scholar] [CrossRef] [PubMed]
  33. Li, H.; Qiu, D.; Yuan, Y.; Wang, X.; Wu, F.; Yang, H.; Wang, S.; Ma, M.; Qian, Y.; Zhan, B.; et al. Trichinella spiralis cystatin alleviates polymicrobial sepsis through activating regulatory macrophages. Int. Immunopharmacol. 2022, 109, 108907. [Google Scholar] [CrossRef]
  34. Chmelař, J.; Kotál, J.; Langhansová, H.; Kotsyfakis, M. Protease Inhibitors in Tick Saliva: The Role of Serpins and Cystatins in Tick-host-Pathogen Interaction. Front. Cell. Infect. Microbiol. 2017, 7, 216. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Multiple sequence alignment of OvCys1–6 and human cystatin C. Predicted OvCys3–6 signal peptides are shown in lowercase letters. The signal peptide, secondary structure and two disulfide bonds are indicated at the top, based on the reference human cystatin C (UniProtKB: P01034). Active site residues are indicated by downward arrows. The AlphaFold-predicted structure of OvCys3 (UniProtKB: A0A075AIV5) is shown at the bottom in orange color. Orange-colored cysteines in OvCys3–5 are predicted to form a second disulfide bond.
Figure 1. Multiple sequence alignment of OvCys1–6 and human cystatin C. Predicted OvCys3–6 signal peptides are shown in lowercase letters. The signal peptide, secondary structure and two disulfide bonds are indicated at the top, based on the reference human cystatin C (UniProtKB: P01034). Active site residues are indicated by downward arrows. The AlphaFold-predicted structure of OvCys3 (UniProtKB: A0A075AIV5) is shown at the bottom in orange color. Orange-colored cysteines in OvCys3–5 are predicted to form a second disulfide bond.
Pathogens 12 00949 g001
Figure 2. (a) SDS-PAGE of crude worm extract (CWE, 20 μg) and excretory-secretory (ES, 20 μg) products prepared from adult O. viverrini. (b) Western blot detection of CWE (20 μg), ES products (20 μg) and rOvCys1, 3 and 4 (100 ng each) reacted with mouse anti-OvCys1, 3 and 4 antisera. Black, white and grey arrows indicate monomer, dimer and trimer forms of the cystatins. (c) Cross-reactivity of anti-rOvCys antisera with each recombinant O. viverrini cystatin (100 ng each). Lanes 1–6 contain rOvCys1–6, respectively.
Figure 2. (a) SDS-PAGE of crude worm extract (CWE, 20 μg) and excretory-secretory (ES, 20 μg) products prepared from adult O. viverrini. (b) Western blot detection of CWE (20 μg), ES products (20 μg) and rOvCys1, 3 and 4 (100 ng each) reacted with mouse anti-OvCys1, 3 and 4 antisera. Black, white and grey arrows indicate monomer, dimer and trimer forms of the cystatins. (c) Cross-reactivity of anti-rOvCys antisera with each recombinant O. viverrini cystatin (100 ng each). Lanes 1–6 contain rOvCys1–6, respectively.
Pathogens 12 00949 g002
Figure 3. Indirect ELISA results obtained with sera from O. viverrini-infected (12 wpi) and uninfected (0 wpi) hamsters (n = 10, each). The whisker lines indicate the minimum and maximum values. The asterisk (**) represents statistical significance (p < 0.01) as calculated using the Wilcoxon matched-pairs signed-rank test.
Figure 3. Indirect ELISA results obtained with sera from O. viverrini-infected (12 wpi) and uninfected (0 wpi) hamsters (n = 10, each). The whisker lines indicate the minimum and maximum values. The asterisk (**) represents statistical significance (p < 0.01) as calculated using the Wilcoxon matched-pairs signed-rank test.
Pathogens 12 00949 g003
Figure 4. Inhibition of bovine cathepsin B and L by recombinant OvCys1, 3, and 4 in comparison with FgStefin2 [12]. The IC50 values are listed in Table 4.
Figure 4. Inhibition of bovine cathepsin B and L by recombinant OvCys1, 3, and 4 in comparison with FgStefin2 [12]. The IC50 values are listed in Table 4.
Pathogens 12 00949 g004
Figure 5. Graphs showing remaining activity of 1 μM of OvCys1, 3 and 4 against mammalian cathepsin L after incubation at 99 °C for 0–180 min (a) and in buffer of pH 3–9 for 30 min (b). Comparable stability has been reported for FgStefin1 and FgStefin2 [11,12].
Figure 5. Graphs showing remaining activity of 1 μM of OvCys1, 3 and 4 against mammalian cathepsin L after incubation at 99 °C for 0–180 min (a) and in buffer of pH 3–9 for 30 min (b). Comparable stability has been reported for FgStefin1 and FgStefin2 [11,12].
Pathogens 12 00949 g005
Table 1. Primer sequences with introduced restriction endonuclease sites (BamHI/PstI, underlined) for cloning of O. viverrini cystatins.
Table 1. Primer sequences with introduced restriction endonuclease sites (BamHI/PstI, underlined) for cloning of O. viverrini cystatins.
IsoformsPrimer Sequences
Forward (5′-3′)Reverse (5′-3′)
OvCys1GGATCCATGCCACTGTGCGGAGGT CTGCAGTCAAAAATAGCCCAACGGGT
OvCys2GGATCCATGCCAATATGCGGTGGCGT CTGCAGTCAAAAATAATCCAACGGATC
OvCys3GGATCCATGTGGGTCAGTTTGGTAG CTGCAGTCAGCAGTCAATCTCTGGAC
OvCys4GGATCCATTAAAGTCACCATGTGGA CTGCAGTTAACATGTGATGGTTTGTTGAC
OvCys5GGATCCATGTGGATTTTATTCCTG CTGCAGTTAGCTTTTGAAGGGACAG
OvCys6GGATCCATGCTGTCGAACTGCTTT CTGCAGCTACGGACATTTTATGAGCT
Table 2. Properties of Opisthorchis viverrini cystatins.
Table 2. Properties of Opisthorchis viverrini cystatins.
IsoformGenBank Accession No.cDNA Size (bp)Amino AcidsPredicted MW (kDa)Cystatin Core Motif (QVVAG)Signal
Sequence
OvCys1OR04739730310010.9QVVSGNo
OvCys2OR04739830310011.1QLVAGNo
OvCys3OR04739937812513.8QIVQGYes
OvCys4OR04740036612113.4QAVMGYes
OvCys5OR04740141113615.1QVVAGYes
OvCys6OR04740235411712.9QVVSGYes
Table 3. Similarity (%) between amino acid sequences of cystatins from Opisthorchis viverrini (Ov) and Fasciola gigantica (Fg) Stefin2.
Table 3. Similarity (%) between amino acid sequences of cystatins from Opisthorchis viverrini (Ov) and Fasciola gigantica (Fg) Stefin2.
OvCys1OvCys2OvCys3OvCys4OvCys5OvCys6FgStefin2
OvCys1 8437.334.626.34032.4
OvCys2 38.932.429.339.529.1
OvCys3 65.144.948.541.9
OvCys4 35.941.545.5
OvCys5 41.230
OvCys6 40.4
FgStefin2
Table 4. IC50 values of recombinant OvCys1, 3 and 4 and FgStefin2 against bovine cathepsins B and L.
Table 4. IC50 values of recombinant OvCys1, 3 and 4 and FgStefin2 against bovine cathepsins B and L.
A.
Enzyme: cathepsin B (1 ng/100 μL)
Substrate: Z-Arg-Arg-AMC (10 μL)
Inhibitors:IC50 (95% CI) (nM):
OvCys1772 (754–793)
OvCys3901 (869–957)
OvCys41104 (1047–?)
FgStefin2246 (192–383)
B.
Enzyme: cathepsin L (1 ng/100 μL)
Substrate: Z-Arg-Arg-AMC (10 μL)
Inhibitors:IC50 (95% CI) (nM):
OvCys1264 (247–288)
OvCys3258 (243–277)
OvCys4322 (288–404)
FgStefin2218 (212–224)
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Geadkaew-Krenc, A.; Grams, R.; Siricoon, S.; Kosa, N.; Krenc, D.; Phadungsil, W.; Martviset, P. Cystatins from the Human Liver Fluke Opisthorchis viverrini: Molecular Characterization and Functional Analysis. Pathogens 2023, 12, 949. https://doi.org/10.3390/pathogens12070949

AMA Style

Geadkaew-Krenc A, Grams R, Siricoon S, Kosa N, Krenc D, Phadungsil W, Martviset P. Cystatins from the Human Liver Fluke Opisthorchis viverrini: Molecular Characterization and Functional Analysis. Pathogens. 2023; 12(7):949. https://doi.org/10.3390/pathogens12070949

Chicago/Turabian Style

Geadkaew-Krenc, Amornrat, Rudi Grams, Sinee Siricoon, Nanthawat Kosa, Dawid Krenc, Wansika Phadungsil, and Pongsakorn Martviset. 2023. "Cystatins from the Human Liver Fluke Opisthorchis viverrini: Molecular Characterization and Functional Analysis" Pathogens 12, no. 7: 949. https://doi.org/10.3390/pathogens12070949

APA Style

Geadkaew-Krenc, A., Grams, R., Siricoon, S., Kosa, N., Krenc, D., Phadungsil, W., & Martviset, P. (2023). Cystatins from the Human Liver Fluke Opisthorchis viverrini: Molecular Characterization and Functional Analysis. Pathogens, 12(7), 949. https://doi.org/10.3390/pathogens12070949

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop